In Situ Hydridization¿¡ ÀÇÇÑ È£ÁöŲº´¿ø¿¡¼ÀÇ Epstein-Barr VisusÀÇ °Ë»ö
Demonstration of Epstein-Barr Virus in Hodgkin's Disease by in Situ Hybridization Method
ÇãÁÖ·É, Àü¸®¸®,
¼Ò¼Ó »ó¼¼Á¤º¸
ÇãÁÖ·É ( )
¼¿ï´ëÇб³ Ä¡°ú´ëÇÐ ±¸°¾Ç¾È¸é¹æ»ç¼±ÇÐ
Àü¸®¸® ( )
¼¿ï´ëÇб³
KMID : 0360319930250060941
Abstract
È£ÁöŲº´°ú Epstein-Barr virus(EBV)¿ÍÀÇ °ü·ÃÀÌ Ç÷û¿ªÇÐÀû ¿¬±¸¿Í ºÐÀÚ»ý¹°ÇÐÀû ¿¬±¸¿¡ ÀÇÇØ ¾Ë·ÁÁ® ¿Ô´Ù. ÃÖ±Ù ¸¹Àº ¿¬±¸µéÀÌ È£ÁöŲº´ Áõ·ÊÀÇ ¾à 50%¿¡¼ EBV¸¦ Áõ¸íÇÏ¿´´Ù. º» ¿¬±¸¿¡¼´Â 1980³âºÎÅÍ 1993³â±îÁö ¼¿ï´ëº´¿ø¿¡¼ Áø´ÜµÈ 61¿¹ÀÇ
È£ÁöŲº´(15¼¼¹Ì¸¸
16¸í, 15~49¼¼ 25¸í, 50¼¼ ÀÌ»ó 21¸í)¿¡¼ÀÇ EBV¹ßÇöÀ»EBER(EBVÀẹ°¨¿°½Ã¿¡ ´Ù·®À¸·Î Àü»çµÇ´Â ÇÙ³»RNA)¿¡ ´ëÇÑ in situ hybridizationÀ¸·Î °Ë»öÇÏ¿´´Ù. EBER´Â 41·Ê¿¡¼ Reed-Sternberg cell°ú ±× º¯Çü¿¡ ¾ç¼ºÀ¸·Î ¹ÝÀÀÇÏ¿´°í, ¸ðµç subtype¿¡¼ °üÂûµÇ¾ú´Ù. °¢
subtype¿¡ µû¸¥ ¹ßÇöºóµµ´Â mixed cellularity 38¿¹Áß 26¿¹(76%), lymphocytic depletion 9¿¹Áß 7¿¹(78%), nodular sclerosis 9¿¹Áß 5¿¹(56%), lymphocytic predominance 6¿¹Áß 4¿¹(66%)¿´´Ù. ¿¬·Éº°·Î º¸¸é 50¼¼ÀÌ»óÀÇ ³ë³â±º(16/21)°ú ¼Ò¾Æ(11/16)¿¡¼
ûÀå³âÃþ(15/25)º¸´Ù ³ôÀº ¾ç¼ºÀ²À» º¸¿´´Ù. ³²³à°£ÀÇ ¾ç¼ºÀ²Àº À¯»çÇÏ¿´´Ù(66% ´ë 67%). ¼Ò¼ö¿¡¼ (6/41), ºñÁ¾¾ç¼ºÀÇ ¼Ò¸²ÇÁ±¸¿¡µµ ¾ç¼º¹ÝÀÀÀ» º¸¿´´Ù. ¼Ò¸²ÇÁ±¸¿¡¸¸ ¾ç¼ºÀ» º¸ÀÏ °æ¿ì¿¡ À½¼ºÀ¸·Î °£ÁÖÇÏ¿´´Ù.
»ó±â °á°ú¸¦ ¿ä¾àÇϸé Çѱ¹ÀÎÀÇ È£ÁöŲº´¿¡¼ÀÇ EBV ¹ßÇö ºóµµ´Â 67%·Î, ±¸¹ÌÀε鿡¼ º¸´Ù ³ôÀ¸¸ç Æó·çÀÎÀ̳ª È¥µÎ¶ó½ºÀο¡¼ÀÇ º¸°íº¸´Ù´Â ³·´Ù. ¿µ¾Æ¸¦ Æ÷ÇÔÇÑ Àü¿¬·É±º¿¡¼ ¾ç¼ºÀÌ °üÂûµÇ¾ú´Ù. ¾ç¼º¹ÝÀÀÀ» º¸ÀÎ Áõ·Ê ´ëºÎºÐÀÌ ¿¹ÈÄ°¡ ³ª»Û ¾ÆÇü¿¡ ¼ÓÇϳª, ¸ðµç
¾ÆÇü¿¡¼ ¾ç¼º¹ÝÀÀÀÌ °üÂûµÇ¾ú´Ù.
Å°¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸